29Jul
Financial Daily Dose 7.29.2019 | Top Story: Pfizer and Mylan Join Forces to Create Generics Powerhouse
Drug giants Pfizer and Mylan have inked a deal that will merge the former’s off-patent drugs with the latter’s generics business, a tie-up that creates a mammoth global seller of lower-priced medicines....
By:
Robins Kaplan LLP
Related
On June 20, 2019, New York lawmakers passed a pair of bills aimed at eliminating pay disparities bas...
Read More >
A new law that comes into effect in Russia on March 12, 2020, introduces antitrust compliance into R...
Read More >
Yesterday, a group of workers at some of the travel plazas in Connecticut, along with members of Loc...
Read More >
The current environment for healthcare transactions is fiercely competitive with high prices, tough ...
Read More >
By mid-2020, special purpose acquisition companies (“SPACs”) had already set records, with over $2...
Read More >
In today’s edition of Daily Compliance News: • SW company discloses possible trade sanction violat...
Read More >